Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials

ObjectiveSteroids-refractory (SR) acute graft-versus-host disease (aGVHD) is a life-threatening condition in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), but the optimal second-line therapy still has not been established. We aimed to perform a systematic review...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Chengxin Luo, Xiangtao Huang, Ling Wei, Guixian Wu, Yarui Huang, Yaqun Ding, Zhen Huang, Jieping Chen, Xi Li, Yunding Zou, Shuangnian Xu
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2023-06-01
Serie:	Frontiers in Immunology
Soggetti:	acute graft-versus-host disease steroids-refractory second-line therapy mesenchymal stroma cells ruxolitinib meta-analysis
Accesso online:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1211171/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!